Media365
DP Technology – the developer of a suite of AI tools used by researchers for work spanning drug design to battery development – has raised more than 800 million yuan (US$114 million) in Series C financing to expand research and development (R&D) and hire talent.
The Beijing-based AI-for-Science (AI4S) start-up said on Wednesday that the round drew backing from a mix of state-linked and venture investors, including Fortune Venture Capital, Beijing Jingguorui Equity Investment Fund, Beijing Artificial Intelligence Industry Investment Fund, Beijing Pharmaceutical and Health Industry Investment Fund, Lenovo Capital and Incubator Group and Oriza Hua.
The funding would be used primarily to recruit talent and expand R&D, the company said.
Founded in 2018 by two Peking University alumni, DP Technology focuses on developing AI4S tools for fundamental research, life sciences and materials science. The sector uses artificial intelligence and advanced computing to accelerate scientific discovery, from molecular simulation to laboratory automation.
DP Technology’s product line-up spans multiple stages of the research process.
Its offerings include Particle Universe, an AI model system for scientific simulation; Bohrium, a cloud-based research platform and asset hub; and Uni-Lab, a laboratory operating system.
The company has also developed Hermite, a computer-aided drug design platform; RiDYMO, an R&D platform targeting previously “undruggable” biological targets; Piloteye, a battery design platform; Lebesgue Intelligent Computing, a computing traffic controller; and SciMaster, a general-purpose scientific AI agent that integrates with its other products.
